🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts https://t.co/4UEGFrMO8U

🏆 ✨It’s almost here✨🏆 🎯 On Oct 6, 16 themes will enter the #HepMadness Showdown and only 1 will walk away as the most impactful advance in hepatology this year. Who are you betting on⁉️ #LiverTwitter @AASLDtweets @HepCommJournal @LTxJournal

🚨Next ⬆️ #GIHepFellowshipBootcamp, #DILI from Complementary & Alternative Med (CAM)‼️ A 📈 cause of liver injury❕🌿 🔎 Get a full history 🔎 Assess degree/pattern of injury 🔎 Rule-out other causes 🔎 Consider biopsy if needed ⭐️ Great approach figure👇 https://t.co/bhNBmLZGXx

Semaglutide FTW (In MASLD / NAFLD) https://t.co/ph9C12R0iu

Cannot express how much this has helped me throughout the start of Fellowship #Livertwitter @BIDMC_GI

📗 Co-Editors @ebtapper and Carmen Chak-Lui Wong share the latest highlights from @HepCommJournal including a state-of-the-art review on #endohepatology, and articles on carbon ion radiotherapy, new HCC treatments, the current clinical uses of artificial liver support systems,

🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts https://t.co/4UEGFrMO8U

📑 Validation of #MELD3.0 in 2 centers from different continents 🌎 In this study, MELD 3.0: 🔹Had highest mortality prediction in women 🔹But not superior to MELD-Na https://t.co/JogzChpNTB

📑 In utero exposure to antihistamines in early pregnancy🤰may ⬆️ the risk of #HCC in adulthood❗️ https://t.co/dXbe7YOHzz

📑 IL-17 signaling in #PSC patient-derived organoids❗️ 💡PSC and non-PSC patient-derived ECO respond differently to IL-17 stimulation, implicating this pathway in the pathogenesis of PSC #OpenAccess https://t.co/6vh88gYZcM

📑 Intrahepatic neutrophil accumulation and extracellular trap formation are associated with posthepatectomy liver failure 💥Inhibiting NETs accelerates liver regeneration! Could this be a game-changer for post-hepatectomy liver failure⁉️ #LiverTwitter https://t.co/DnIv67H5Hy

Mortality is still 12% at 6 months… not a benign condition at all #LiverX

🚨 #GIHepFellowshipBootcamp continues‼️ Your 📟 goes off at 3am, a patient is having an EV bleed 😳 Relax 🧘‍♀️, you got this❕This 📑 will teach you the 🔑s to manage EV🩸❕ 🩸Resuscitation 🩸Vasoactive Tx 🩸Antibiotics 🩸Endoscopy 🩸Preempt. TIPS❓ https://t.co/wXAXo6vdNJ

📑 Short-term costs of #alcohol-associated hepatitis care in different clinical settings‼️ https://t.co/446nsYNyHZ

📑 Treatment of #pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry❕ #OpenAccess https://t.co/HEtEibPmMe

📑 Enhancement of hepatic differentiation from induced pluripotent stem cells by suppressing epithelial–mesenchymal transition❗️ #OpenAccess https://t.co/ebV7yRnlkY

📑 Moderate alcohol-associated hepatitis: A real-world multicenter study‼️ mAH has ⬆️ 💀 rates, driven by age, organ failure, infections, and variceal 🩸 . Current risk scores perform poorly in mAH https://t.co/oi9ZNE20oY

📑 Information overload, financial constraints, and psychological burdens are among the barriers faced by marginalized groups seeking curative treatments for #HCC‼️ https://t.co/qt9sdy2Zym

📑 Unraveling enhanced liver regeneration in ALPPS: Integrating multi-omics profiling and in vivo CRISPR in mouse models https://t.co/gvBQAy8WeR

📑 Natural language processing to detect steatotic liver disease from the EHR is fast, scalable, and highly accurate‼️ AI is transforming liver disease detection ➡️ intervention❕ @bkyalwazi @jlouissaint89 #LiverTwitter #AI #NLP #SLD https://t.co/Vl9zy9hjhZ

📗 Co-Editor @ebtapper shares highlights from @HepCommJournal including #livertransplantation, unmet needs of patients with chronic #liverdisease, addiction care & #hepatology for alcohol use disorder, & more! View the latest issue: https://t.co/8G5uOYkpSm